Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vulcan Two Group PLC ( (GB:VUL) ) has shared an announcement.
Vulcan Two Group plc has completed the acquisitions of online pharmacy businesses CloudRx, Hyperdrug and Webmed, advancing its strategy to create the UK’s leading regulated ePharmacy. The deals, together constituting a reverse takeover under AIM rules, were accompanied by a £40 million institutional placing to support the enlarged group’s growth and integration plans.
Following shareholder approval, the company’s existing and newly issued shares have been readmitted to trading on AIM, with total issued share capital now standing at 27,275,000 ordinary shares. The board has also been strengthened with the appointment of Keith Butcher as a director, signaling a more mature governance structure for the expanded business and setting a clearer framework for investors tracking voting rights and disclosures.
More about Vulcan Two Group PLC
Vulcan Two Group plc is a UK-based company focused on building a leading regulated online pharmacy platform through a buy-and-build strategy. By acquiring established digital pharmacy businesses, the group aims to consolidate and scale its presence in the UK ePharmacy market, serving consumers via internet-based prescription and healthcare services.
Average Trading Volume: 9,949
Technical Sentiment Signal: Strong Sell
See more data about VUL stock on TipRanks’ Stock Analysis page.